Changeflow GovPing Healthcare Alabama DPH Highlights Risks of Cannabinoid Pro...
Routine Notice Added Final

Alabama DPH Highlights Risks of Cannabinoid Products During Poison Prevention Week

Favicon for www.alabamapublichealth.gov index.html
Published March 18th, 2026
Detected March 18th, 2026
Email

Summary

The Alabama Department of Public Health issued a notice highlighting the risks associated with cannabinoid products, particularly for children, during National Poison Prevention Week. In 2025, the Alabama Poison Information Center managed 469 cases involving cannabinoid exposures.

What changed

The Alabama Department of Public Health has issued a notice for National Poison Prevention Week, drawing attention to the potential risks posed by cannabinoid-containing products. The notice highlights that in 2025, the Alabama Poison Information Center (APIC) managed 469 cases involving cannabinoid exposures, with 59 reported so far in 2026, many involving children under two years old. It explains that various cannabinoids, including delta-8 THC and delta-10 THC, are increasingly available in products that may resemble snacks and candies, and that these products are often unregulated by the FDA, leading to potential variations in content, strength, purity, and the presence of contaminants.

Consumers are advised to exercise caution with cannabinoid products and store them securely to prevent accidental exposure, especially by children and pets. The notice encourages reporting adverse events to the FDA's MedWatch program. While this is a public health awareness initiative and not a regulatory mandate with specific compliance deadlines or penalties, it serves as a reminder for manufacturers and retailers about the importance of product safety and for consumers about safe storage and potential health risks.

Source document (simplified)

Education Health

Poison Prevention Week: Products Containing Cannabinoids

  • Newsroom
  • March 18, 2026 This National Poison Prevention Week, the Alabama Department of Public Health is once again bringing attention to cannabinoid-containing products and the potential risks they pose.

In 2025, the Alabama Poison Information Center (APIC) managed 469 cases involving exposure to cannabinoids. So far in 2026, 59 exposures have been reported and managed by APIC. Exposures have occurred in children less than 2 years old. These cases highlight the importance of keeping cannabinoid-containing products out of the reach of children and pets.

What are Cannabinoids?

Cannabinoids are compounds that can be extracted from cannabis plants. Many people are familiar with cannabidiol (CBD) and delta-9 tetrahydrocannabinol (delta-9 THC), which is the primary psychoactive compound associated with marijuana. However, cannabis plants contain dozens of cannabinoids and more continue to emerge in consumer products.

In recent years, compounds such as delta-8 tetrahydrocannabinol (delta-8 THC), delta-10 tetrahydrocannabinol (delta-10 THC), and others have become increasingly available for purchase online or at retail locations such as gas stations, vape shops, and convenience stores. They often appear in forms that resemble popular snacks and candies, including gummies, cookies, chocolates, and beverages. Packaging and labeling may make these products especially appealing to children.

Some cannabinoids, including delta-8 THC and delta-10 THC, occur naturally in cannabis plants only in very small amounts. To produce the larger quantities found in many commercial products, manufacturers may chemically convert other cannabinoids (often CBD) into these compounds. These processes can involve other potentially harmful chemicals, and the facilities where products are made may not always follow consistent safety or quality standards.

In addition, many cannabinoid products currently on the market are not evaluated or approved by the U.S. Food and Drug Administration (FDA) and remain unregulated. Because of this, the contents, strength, and purity of these products may vary widely. Some products may contain higher amounts of THC than expected or include contaminants such as residual solvents, heavy metals, or other substances.

Cannabinoid Exposure

The FDA and poison control centers across the country have received reports of adverse health effects linked to cannabinoid products. Reported symptoms have ranged from vomiting and confusion to hallucinations, excessive sedation, and loss of consciousness.

Consumers should use caution when considering products that contain cannabinoids and store any such products securely to prevent accidental exposure.

If you think someone is having a serious reaction to a cannabinoid-containing product, call your local poison control center at 1-800-222-1222. Consumers are also encouraged to report adverse events to the FDA’s MedWatch program.

National Poison Prevention Week, recognized during the third full week of March each year, was established by Congress in 1961 to raise awareness about accidental poisoning and how it can be prevented.

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
State Health
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Consumers Manufacturers
Geographic scope
State (Alabama)

Taxonomy

Primary area
Public Health
Operational domain
Compliance
Topics
Pharmaceuticals Consumer Protection

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when index.html publishes new changes.

Free. Unsubscribe anytime.